Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs

Chelsea B. Greenberg; Pedro A. Boria; Antonella Borgatti-Jeffreys; Rose E. Raskin; Michael D. Lucroy

doi:10.5326/0430027

Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs

Chelsea B. Greenberg, Pedro A. Boria, Antonella Borgatti-Jeffreys, Rose E. Raskin, Michael D. Lucroy

Veterinary Clinical Sciences

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Dogs with histologically confirmed lymphoma were treated with a 14-week induction chemotherapy protocol that included dexamethasone. A phase II clinical trial was done using a standard two-stage design. Complete remission occurred in 21 (88%) dogs, with a median initial progression-free interval of 186 days. Toxicity was mild and self-limiting in the majority of dogs.

Original language	English (US)
Pages (from-to)	27-32
Number of pages	6
Journal	Journal of the American Animal Hospital Association
Volume	43
Issue number	1
DOIs	https://doi.org/10.5326/0430027
State	Published - Jan 1 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.5326/0430027

OpenUrl availability

Full text

Cite this

@article{1b0724d7631845b09239c5c2bf4795fb,

title = "Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs",

abstract = "Dogs with histologically confirmed lymphoma were treated with a 14-week induction chemotherapy protocol that included dexamethasone. A phase II clinical trial was done using a standard two-stage design. Complete remission occurred in 21 (88%) dogs, with a median initial progression-free interval of 186 days. Toxicity was mild and self-limiting in the majority of dogs.",

author = "Greenberg, {Chelsea B.} and Boria, {Pedro A.} and Antonella Borgatti-Jeffreys and Raskin, {Rose E.} and Lucroy, {Michael D.}",

year = "2007",

month = jan,

day = "1",

doi = "10.5326/0430027",

language = "English (US)",

volume = "43",

pages = "27--32",

journal = "Journal of the American Animal Hospital Association",

issn = "1547-3317",

publisher = "American Animal Hospital Association",

number = "1",

}

TY - JOUR

T1 - Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs

AU - Greenberg, Chelsea B.

AU - Boria, Pedro A.

AU - Borgatti-Jeffreys, Antonella

AU - Raskin, Rose E.

AU - Lucroy, Michael D.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Dogs with histologically confirmed lymphoma were treated with a 14-week induction chemotherapy protocol that included dexamethasone. A phase II clinical trial was done using a standard two-stage design. Complete remission occurred in 21 (88%) dogs, with a median initial progression-free interval of 186 days. Toxicity was mild and self-limiting in the majority of dogs.

AB - Dogs with histologically confirmed lymphoma were treated with a 14-week induction chemotherapy protocol that included dexamethasone. A phase II clinical trial was done using a standard two-stage design. Complete remission occurred in 21 (88%) dogs, with a median initial progression-free interval of 186 days. Toxicity was mild and self-limiting in the majority of dogs.

UR - http://www.scopus.com/inward/record.url?scp=33947106876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947106876&partnerID=8YFLogxK

U2 - 10.5326/0430027

DO - 10.5326/0430027

M3 - Article

C2 - 17209082

AN - SCOPUS:33947106876

SN - 1547-3317

VL - 43

SP - 27

EP - 32

JO - Journal of the American Animal Hospital Association

JF - Journal of the American Animal Hospital Association

IS - 1

ER -

Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs

Abstract

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this